Patrick Fisher serves as President of Global Biologics and Limb Reconstruction at Orthofix Medical Inc., where he leads the strategic direction and global operations for the company's biologics portfolio and advanced limb reconstruction solutions. With over 25 years of experience in the medical device industry, Fisher has built a distinguished career focused on orthopedics, regenerative medicine, and innovative therapies for complex musculoskeletal conditions. He joined Orthofix in 2018, bringing expertise from senior leadership roles at Medtronic and Zimmer Biomet, where he spearheaded the development and commercialization of biologics platforms that revolutionized bone healing and tissue regeneration. Under Fisher's leadership, Orthofix's Biologics and Limb Reconstruction business has achieved significant milestones, including the launch of next-generation osteogenic proteins and customizable limb salvage systems that have improved patient outcomes in trauma and oncology cases. He has driven double-digit revenue growth, expanded market access in over 50 countries, and fostered key partnerships with leading research institutions. Fisher's achievements include securing multiple FDA approvals for breakthrough devices, authoring influential publications in journals like the Journal of Bone and Joint Surgery, and earning the MedTech Innovator Award for his contributions to limb reconstruction technologies. Fisher holds a Bachelor of Science in Biomedical Engineering from Johns Hopkins University and an MBA from the Wharton School of the University of Pennsylvania. Passionate about advancing personalized medicine, he continues to champion R&D investments at Orthofix, positioning the company as a leader in biologics-driven solutions for global orthopedic challenges.